Advanced Solid Tumors Clinical Trials in Hangzhou, Zhejiang
21 recruitingHangzhou, Zhejiang, China
Showing 1–20 of 21 trials
Recruiting
Phase 1Phase 2
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Phase 2
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Solid TumorsHER2 Mutation
Bayer111 enrolled54 locationsNCT06760819
Recruiting
Phase 1Phase 2
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Metastatic Solid TumorsLocally Advanced Solid Tumors
Turning Point Therapeutics, Inc.500 enrolled165 locationsNCT03093116
Recruiting
Phase 1
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors
HER-2 Positive Advanced Solid Tumors
D3 Bio (Wuxi) Co., Ltd128 enrolled9 locationsNCT05957536
Recruiting
Phase 1Phase 2
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
Advanced Solid Tumors
Astellas Pharma Global Development, Inc.366 enrolled44 locationsNCT05083481
Recruiting
Phase 1
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
Advanced Solid Tumors
Merck Sharp & Dohme LLC830 enrolled73 locationsNCT05067283
Recruiting
Phase 1
Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection
Advanced Solid Tumors
Bio-Thera Solutions182 enrolled2 locationsNCT05620017
Recruiting
Phase 1Phase 2
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd63 enrolled16 locationsNCT05944224
Recruiting
Phase 1
GenSci143 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd.180 enrolled9 locationsNCT07252414
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.155 enrolled21 locationsNCT06384352
Recruiting
Phase 1Phase 2
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.252 enrolled43 locationsNCT06459973
Recruiting
Phase 1Phase 2
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Advanced Solid Tumors
DualityBio Inc.862 enrolled107 locationsNCT05914116
Recruiting
Phase 1Phase 2
A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Advanced Solid TumorsKRAS G12D Mutations
Genfleet Therapeutics (Shanghai) Inc.407 enrolled20 locationsNCT06500676
Recruiting
Phase 1
A Phase 1 Study to Investigate FP008 in Subjects With Advanced Solid Tumors
Advanced Solid Tumors
Zhuhai Fapon Biopharma Co., Ltd.108 enrolled3 locationsNCT06990698
Recruiting
Phase 1
Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments
Zhejiang University12 enrolled1 locationNCT07021534
Recruiting
Early Phase 1
AMT-676 in Patients With Advanced Solid Tumors
Advanced Solid Tumors
Multitude Therapeutics Inc.24 enrolled13 locationsNCT06400485
Recruiting
Phase 1
A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors
Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.162 enrolled30 locationsNCT06394414
Recruiting
Phase 1Phase 2
AMT-116 in Patients with Solid Tumors
Advanced Solid Tumors
Multitude Therapeutics Inc.144 enrolled7 locationsNCT06782334
Recruiting
Early Phase 1
A Dose Escalation and Dose Expansion Trial of WTX212A in the Treatment of Patients with Advanced Malignant Tumors
Unresectable or Metastatic Advanced Solid Tumors
Zhejiang University44 enrolled1 locationNCT06026605
Recruiting
Phase 1
A Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
Advanced Solid TumorsRefractory LymphomaRelapsed Hematologic Malignancy
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.111 enrolled8 locationsNCT06615193